Clinical Trials Browser

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT07245095 2025-11-24

NACSIMET

Phase 2 Recruiting

132 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04481035 2025-07-31

NF1NAC

Phase 2 Completed

5 enrolled 10 charts

CNS

Neurofibromatosis 1

NCT02569957 2025-05-04

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Terminated

1 enrolled 5 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06354712 2025-01-15

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Phase 2 Recruiting

50 enrolled

Stomatitis, Ulcer

NCT06024031 2024-11-07

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

Phase 2 Active not recruiting

30 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04481048 2024-10-09

DoDNAC

Phase 2 Active not recruiting

58 enrolled

CNS

Neurofibromatosis 1

NCT03982537 2022-12-19

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Phase 2 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Phase 2 Unknown

62 enrolled

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

NCT02123511 2019-04-30

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Phase 2 Completed

34 enrolled 16 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms, Mucositis

NCT01726465 2013-11-13

MENHIR

Phase 2 Terminated

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

80 enrolled

Dermatologic

Melanoma

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Phase 2 Completed

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

60 enrolled

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

Clinical Trials

RESPIRE-ILD

NACSIMET

NF1NAC

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

DoDNAC

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

MENHIR

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Use of N-Acetylcysteine During Liver Procurement

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training